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Wojciech Wojakowski, MD, PHDA 73-year-old lady was hospitalized becauseof non–ST-segment elevation myocardialinfarction (NSTEMI). She suffered a myocar-
dial infarction 18 years earlier and underwent
coronary artery bypass grafting (CABG) with theFrom the 3rd Department of Cardiology, Medical University of Silesia, Katow
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the aorta (Ao) to the left anterior descending coronary
artery (Ao-LAD), to the circumﬂex coronary artery,
and to the posterior descending artery 13 years ago,
and then percutaneous coronary intervention (PCI)FIGURE 1 Vulnerable Neoatheroma in BMS 2 Years
After PCI of a Coronary SVG
The ﬁgure presents an angiogram (background) and
optical coherence tomography (OCT) images of the
in-stent restenosis in bare-metal stents (BMS) implanted
in the coronary saphenous vein graft (SVG) to the left
descending artery (LAD) (A, B, and C). Panel A presents
stent struts covered by neointima that did not narrow the
lumen of the vessel. Panel B presents the excessive
growth of the neointima with neovascularization (micro-
vessels, white arrow). Panel C presents a thin ﬁbrous cap
(60 mm, white arrow) covering the lipid core of the
neointima (neoatheroma) in the BMS. The OCT images in
panels A, B, and C correspond to the locations indicated by
the similarly labeled white lines on the angiogram.
PCI ¼ percutaneous coronary intervention.
ice, Poland. All the authors have reported that they
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e96of the Ao-LAD with implantation of 2 bare-metal
stents (BMS) (4.0  22 mm to the medial and 4.5 
15 mm to the proximal segment) 11 years after
CABG. She also had hypertension, diabetes, and
hyperlipidemia. The NSTEMI occurred 2 years after
the PCI, and the coronary angiogram revealed a
culprit lesion: in-stent restenosis of the BMS in the
medial segment of the Ao-LAD. Quantitative coronary
angiography revealed 86% vessel stenosis with a min-
imal lumen diameter ¼ 1.5 mm. Intravascular optical
coherence tomography (OCT) presented excessive
hyperplasia of the neointima that signiﬁcantly nar-
rowed the SVG (minimal lumen area ¼ 1.7 mm2) and
formed neoatherosclerosis within the BMS. Interest-
ingly, this neoatheroma exhibited features of native
vulnerable plaque. OCT presented a thin ﬁbrous cap
(60 mm) covering the lipid core and microvessels in
the neointima (Fig. 1). The lesion was successfully
treated with implantation of the PROMUS ElementPlus drug-eluting stent (3.5  24 mm, Boston Scien-
tiﬁc, Natick, Massachusetts) and with the use of
a SpiderFX Embolic Protection Device (Spider
4.0 mm, ev3 Endovascular, Plymouth, Minnesota).
However, despite the presence of lipid-rich plaque,
none of the remnants were caught by the distal
protection device, although transient slow-ﬂow was
observed.
Such a ﬁnding suggests that neoatherosclerosis in
BMS implanted in the SVG occurs earlier as compared
with BMS implanted in native coronary arteries (1). As
was previously reported, necrotic core formation
began 5 years after BMS implantation in the coronary
arteries (2).
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